KB
Kunal Bhatia
About Kunal Bhatia
Data last updated:
Kunal Bhatia has 9 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Maestoso Hospitality Llp and Supermax Laboratories Private Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Supermax Laboratories Private Limited U21000DL2025PTC443678 | Director | 28 Feb 2025 | 2025 | – | Active |
| Maxcord Pharmaceuticals Private Limited U21002DL2023PTC420088 | Director | 15 Sep 2023 | 2023 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Maestoso Hospitality Llp AAI-1921 | Designated Partner | 05 Jan 2017 | 2017 | – | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kunal Bhatia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kunal Bhatia
Kunal Bhatia has 9 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Maestoso Hospitality Llp and Supermax Laboratories Private Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.
Kunal Bhatia is associated with 2 companies as Designated Partner and Director, including Supermax Laboratories Private Limited, Maxcord Pharmaceuticals Private Limited.
Kunal Bhatia has expertise in General Business.
Kunal Bhatia has 9 years in corporate governance.
Kunal Bhatia currently holds positions at 2 companies: Supermax Laboratories Private Limited, Maxcord Pharmaceuticals Private Limited.